Steven Glazer

964 total citations
24 papers, 680 citations indexed

About

Steven Glazer is a scholar working on Hematology, Microbiology and Physiology. According to data from OpenAlex, Steven Glazer has authored 24 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Microbiology and 3 papers in Physiology. Recurrent topics in Steven Glazer's work include Hemophilia Treatment and Research (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Platelet Disorders and Treatments (5 papers). Steven Glazer is often cited by papers focused on Hemophilia Treatment and Research (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Platelet Disorders and Treatments (5 papers). Steven Glazer collaborates with scholars based in Denmark, United States and Belgium. Steven Glazer's co-authors include Ulla Hedner, Russell K. Portenoy, Jörgen Kristensen, A. Killander, Carsten Helleberg, Erik Hippe, Mette Holm, Jan Johansson, Ulf‐Henrik Mellqvist and Jack Kutti and has published in prestigious journals such as Blood, American Heart Journal and British Journal of Haematology.

In The Last Decade

Steven Glazer

23 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Glazer Denmark 14 369 79 71 68 64 24 680
Jane A. Hunt United Kingdom 12 75 0.2× 54 0.7× 52 0.7× 12 0.2× 29 0.5× 18 616
Leo Nicolai Germany 10 108 0.3× 12 0.2× 20 0.3× 44 0.6× 17 0.3× 23 362
H J Ward United States 9 116 0.3× 45 0.6× 21 0.3× 40 0.6× 62 1.0× 15 429
E. A. Lyons United States 8 171 0.5× 22 0.3× 34 0.5× 10 0.1× 30 0.5× 15 549
Saundra Rice Murray United States 5 67 0.2× 23 0.3× 35 0.5× 41 0.6× 24 0.4× 10 259
Orhan Zengin Türkiye 14 44 0.1× 17 0.2× 39 0.5× 9 0.1× 16 0.3× 30 499
Ibtissam Youlyouz‐Marfak Morocco 14 142 0.4× 5 0.1× 36 0.5× 17 0.3× 54 0.8× 38 695
García Díaz Spain 13 16 0.0× 19 0.2× 133 1.9× 38 0.6× 16 0.3× 67 503
G. Armstrong United Kingdom 12 142 0.4× 8 0.1× 50 0.7× 35 0.5× 161 2.5× 25 691
Ghazi Omar Tadmouri Türkiye 14 258 0.7× 9 0.1× 37 0.5× 18 0.3× 336 5.3× 31 957

Countries citing papers authored by Steven Glazer

Since Specialization
Citations

This map shows the geographic impact of Steven Glazer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Glazer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Glazer more than expected).

Fields of papers citing papers by Steven Glazer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Glazer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Glazer. The network helps show where Steven Glazer may publish in the future.

Co-authorship network of co-authors of Steven Glazer

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Glazer. A scholar is included among the top collaborators of Steven Glazer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Glazer. Steven Glazer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O′Neill, Eoin, Lucy Curham, Gavin McManus, et al.. (2024). Neonatal infection with Bordetella pertussis promotes autism-like phenotypes in mice. iScience. 28(1). 111548–111548. 4 indexed citations
2.
Glazer, Steven, et al.. (2018). The pertussis hypothesis: Bordetella pertussis colonization in the etiology of asthma and diseases of allergic sensitization. Medical Hypotheses. 120. 101–115. 15 indexed citations
3.
Glazer, Steven, et al.. (2016). The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer’s disease. Immunobiology. 222(2). 228–240. 15 indexed citations
4.
Glazer, Steven, et al.. (2016). Potential Role of Bordetella Pertussis in Celiac Disease. 3(2). 75–76. 3 indexed citations
5.
Glazer, Steven, et al.. (2015). The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis. Immunobiology. 221(4). 512–515. 9 indexed citations
6.
Peerlinck, Kathelijne, Thomas Vanassche, Christophe Vandenbriele, et al.. (2013). Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. Thrombosis and Haemostasis. 109(6). 1091–1098. 13 indexed citations
8.
Verhamme, Peter, Steve Pakola, Thomas Jensen, et al.. (2010). Tolerability and pharmacokinetics of TB-402 in healthy male volunteers. Clinical Therapeutics. 32(6). 1205–1220. 21 indexed citations
9.
Riisbro, Rikke, Lena Winstedt, Steve Pakola, et al.. (2009). Abstract A3: A first-in-man, phase I, dose escalation study of TB-403, a monoclonal antibody directed against PlGF, in healthy male subjects. Molecular Cancer Therapeutics. 8(12_Supplement). A3–A3. 1 indexed citations
10.
Verhamme, Peter, Steve Pakola, Marc Jacquemin, et al.. (2007). Phase I Clinical Trial of a Novel, Long-Acting Antithrombotic Drug: A Human Monoclonal Antibody Partially Inhibiting FVIII Activity.. Blood. 110(11). 312–312. 1 indexed citations
11.
Nilsson, Jan, et al.. (2006). Antibodies against oxidized low-density lipoprotein for the treatment of vulnerable plaques.. PubMed. 7(9). 815–9. 3 indexed citations
12.
Madan, Mina, Scott D. Berkowitz, Douglas J. Christie, et al.. (2001). Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention. American Heart Journal. 141(2). 226–233. 45 indexed citations
13.
Glazer, Steven. (1999). The Heart of Learning. 17 indexed citations
14.
Kristensen, Jörgen, A. Killander, Erik Hippe, et al.. (1996). Clinical Experience with Recombinant Factor VIla in Patients with Thrombocytopenia. Pathophysiology of Haemostasis and Thrombosis. 26(Suppl. 1). 159–164. 160 indexed citations
15.
Glazer, Steven, et al.. (1995). Clinical update on the use of recombinant factor VII. Advances in experimental medicine and biology. 386. 163–174. 29 indexed citations
16.
Glazer, Steven, et al.. (1993). Experience With Recombinant Factor VIIA in an Infant Hemophiliac With Inhibitors to FVIILC Undergoing Emergency Central Line Placement. Journal of Pediatric Hematology/Oncology. 15(1). 77–79. 10 indexed citations
17.
Hedner, Ulla, et al.. (1993). Recombinant Activated Factor VII in the Treatment of Bleeding Episodes in Patients With Inherited and Acquired Bleeding Disorders. Transfusion Medicine Reviews. 7(2). 78–83. 69 indexed citations
18.
Hedner, Ulla & Steven Glazer. (1992). Management of Hemophilia Patients with Inhibitors. Hematology/Oncology Clinics of North America. 6(5). 1035–1046. 31 indexed citations
19.
Schmidt, Mary Lou, et al.. (1991). PROLONGED RECOMBINANT ACTIVATED FACTOR VII (rFVIIa) TREATMENT FOR SEVERE BLEEDING IN A FACTOR‐IX‐DEFICIENT PATIENT WITH AN INHIBITOR. British Journal of Haematology. 78(3). 460–463. 17 indexed citations
20.
Glazer, Steven & Russell K. Portenoy. (1991). Systemic local anesthetics in pain control. Journal of Pain and Symptom Management. 6(1). 30–39. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026